| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0003 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |